Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy in Heart Transplantation: New Strategies and Preliminary Results in Endomyocardial Biopsies

Tacrolimus (TAC) is an immunosuppressant drug approved both in the US and in the EU, widely used for the prophylaxis of organ rejection after transplantation. This is a critical dose drug: low levels in whole blood can lead to low exposure and a high risk of acute rejection, whereas overexposure put...

Description complète

Détails bibliographiques

Auteurs principaux:	Simona De Gregori, Annalisa De Silvestri, Barbara Cattadori, Andrea Rapagnani, Riccardo Albertini, Elisa Novello, Monica Concardi, Eloisa Arbustini, Carlo Pellegrini
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2022-06-01
Collection:	Pharmaceutics
Sujets:	heart transplantation acute rejection therapeutic drug monitoring tacrolimus endomyocardial biopsies
Accès en ligne:	https://www.mdpi.com/1999-4923/14/6/1247
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!